Try our mobile app

Published: 2021-08-20 16:55:58 ET
<<<  go to MRK company page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)   August 20, 2021
 (August 19, 2021)

Merck & Co., Inc.
(Exact name of registrant as specified in its charter)

New Jersey
 1-6571
22-1918501
(State or other jurisdiction of incorporation)
 (Commission File Number)
 (IRS Employer Identification No.)

2000 Galloping Hill Road, Kenilworth, NJ
  
07033
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code  
(908) 740-4000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b–2 of the Securities Exchange Act of 1934.
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
  
Trading
Symbol(s)
  
Name of Each Exchange
on which Registered
         
Common Stock ($0.50 par value)
   MRK
   New York Stock Exchange
1.125% Notes due 2021
  
MRK/21
   New York Stock Exchange
0.500% Notes due 2024
   MRK24
   New York Stock Exchange
1.875% Notes due 2026
   MRK/26
  
New York Stock Exchange
2.500% Notes due 2034
   MRK/34
  
New York Stock Exchange
1.375% Notes due 2036
   MRK36A
   New York Stock Exchange

Item 5.02 –
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company”) on August 20, 2021, attached as Exhibit 99.1, announcing the resignation of Leslie A. Brun from the Company’s Board of Directors effective August 19, 2021.

Item 9.01 –
Financial Statements and Exhibits.
 
(d)
Exhibits:

Exhibit Number

Description
   
99.1

Press Release issued August 20, 2021.

2
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Merck & Co., Inc.
   
Date: August 20, 2021
By:
/s/ Kelly E. W. Grez
   
Name:
  Kelly E. W. Grez
   
Title: 
 Deputy Corporate Secretary

3
EXHIBIT INDEX

Exhibit No.
 Description of Exhibit
   
Press Release issued August 20, 2021.